Impacts of endometrioma on ovarian aging from basic science to clinical management
Frontiers in Endocrinology · 04.01.2023 · 13
DOI: 10.3389/fendo.2022.1073261 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Endocrinology, online erschienen am 04.01.2023. Verfasst von Zhouyurong Tan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynaecology, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China. Hauptthemen laut MEDLINE: Endometriosis, Infertility, Female, Menopause, Premature. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 186 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Endometriosis is a common reproductive disorder characterized by the presence of endometrial implants outside of the uterus. It affects ~1 in 10 women of reproductive age. Endometriosis in the ovary, also known as endometrioma (OMA), is the most frequent implantation site and the leading cause of reproductive failure in affected women. Ovarian aging is one of the characteristic features of OMA, however its underlying mechanism yet to be determined. Accumulated evidence has shown that pelvic and local microenvironments in women with OMA are manifested, causing detrimental effects on ovarian development and functions. Whilst clinical associations of OMA with poor ovarian reserve, premature ovarian insufficiency, and early menopause have been reported. Moreover, surgical ablation, fenestration, and cystectomy of OMA can further damage the normal ovarian reservoir, and trigger hyperactivation of primordial follicles, subsequently resulting in the undesired deterioration of ovarian functions. Nevertheless, there is no effective treatment to delay or restore ovarian aging. This review comprehensively summarised the pathogenesis and study hypothesis of ovarian aging caused by OMA in order to propose potential therapeutic targets and interventions for future studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Obstetrics and Gynaecology, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China.
- Department of Obstetrics and Gynaecology, The Second Affiliated Hospital, The Chinese University of Hong Kong, Shenzhen, China.
- Reproduction and Development, Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China.
- School of Biomedical Sciences, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China.
- Chinese University of Hong Kong-Sichuan University Joint Laboratory in Reproductive Medicine, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China.
Zitieren
APA
Tan, Z., Gong, X., Li, Y., Hung, S. W., Huang, J., Wang, C. C., & Chung, J. P. W. (2023). Impacts of endometrioma on ovarian aging from basic science to clinical management. Frontiers in Endocrinology, 13. https://doi.org/10.3389/fendo.2022.1073261
Vancouver
Tan Z, Gong X, Li Y, Hung SW, Huang J, Wang CC, et al. Impacts of endometrioma on ovarian aging from basic science to clinical management. Frontiers in Endocrinology. 2023;13. doi:10.3389/fendo.2022.1073261
BibTeX
@article{Tan2023,
author = {Tan, Zhouyurong and Gong, Xue and Li, Yiran and Hung, Sze Wan and Huang, Jin and Wang, Chi Chiu and Chung, Jacqueline Pui Wah},
title = {Impacts of endometrioma on ovarian aging from basic science to clinical management},
journal = {Frontiers in Endocrinology},
year = {2023},
volume = {13},
doi = {10.3389/fendo.2022.1073261}
}
EUVIMED